Cargando…
Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial
INTRODUCTION: There is significant potential to improve outcomes for patients with lung cancer in terms of quality of life and survival. There is some evidence that prehabilitation can help, but, to date, this has only been tested in surgical populations, despite 70%–80% of patients with lung cancer...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357652/ https://www.ncbi.nlm.nih.gov/pubmed/37460263 http://dx.doi.org/10.1136/bmjopen-2023-072367 |
_version_ | 1785075539775586304 |
---|---|
author | Wade-Mcbane, Kelly King, Alex Urch, Catherine Johansson, Lina Wells, Mary |
author_facet | Wade-Mcbane, Kelly King, Alex Urch, Catherine Johansson, Lina Wells, Mary |
author_sort | Wade-Mcbane, Kelly |
collection | PubMed |
description | INTRODUCTION: There is significant potential to improve outcomes for patients with lung cancer in terms of quality of life and survival. There is some evidence that prehabilitation can help, but, to date, this has only been tested in surgical populations, despite 70%–80% of patients with lung cancer in the UK receiving non-surgical treatment. The physiological and psychological benefits of prehabilitation seen in surgical patients could be extrapolated to those receiving non-surgical treatment, particularly in such a poor prognosis group. With patients and healthcare professionals, we have co-designed a personalised and evidence-based prehabilitation programme. This draws on a conceptual framework that aligns with patient values and needs as well as functional goals. We aim to investigate whether this programme is feasible to implement and evaluate in clinical practice. METHODS AND ANALYSIS: An open-label, single-group feasibility study incorporating quantitative assessments, a qualitative free text questionnaire and reflective field notes. Thirty participants will be recruited over an eight-month period from a single London teaching hospital. All recruited participants will receive a personalised prehabilitation programme during their oncological treatment. This includes a one-hour face-to-face appointment prior to, at week three and at week six of their treatment regimen as well as a weekly telephone call. Interventions including nutrition, physical activity and psychological well-being are stratified according to a patient’s priorities, level of readiness and expressed needs. The primary outcome will be feasibility of the personalised prehabilitation programme in clinical practice by investigating areas of uncertainty regarding patient recruitment, attrition, treatment fidelity, intervention adherence and acceptability of study outcome measures. Secondary outcomes will include quality of life, functional capacity and grip strength. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Health Research Authority (reference number 22/PR/0390). Results of this study will be disseminated through publication in peer-reviewed articles, presentations at scientific conferences and in collaboration with patient and public involvement representatives. TRIAL REGISTRATION NUMBER: NCT05318807. |
format | Online Article Text |
id | pubmed-10357652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-103576522023-07-21 Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial Wade-Mcbane, Kelly King, Alex Urch, Catherine Johansson, Lina Wells, Mary BMJ Open Oncology INTRODUCTION: There is significant potential to improve outcomes for patients with lung cancer in terms of quality of life and survival. There is some evidence that prehabilitation can help, but, to date, this has only been tested in surgical populations, despite 70%–80% of patients with lung cancer in the UK receiving non-surgical treatment. The physiological and psychological benefits of prehabilitation seen in surgical patients could be extrapolated to those receiving non-surgical treatment, particularly in such a poor prognosis group. With patients and healthcare professionals, we have co-designed a personalised and evidence-based prehabilitation programme. This draws on a conceptual framework that aligns with patient values and needs as well as functional goals. We aim to investigate whether this programme is feasible to implement and evaluate in clinical practice. METHODS AND ANALYSIS: An open-label, single-group feasibility study incorporating quantitative assessments, a qualitative free text questionnaire and reflective field notes. Thirty participants will be recruited over an eight-month period from a single London teaching hospital. All recruited participants will receive a personalised prehabilitation programme during their oncological treatment. This includes a one-hour face-to-face appointment prior to, at week three and at week six of their treatment regimen as well as a weekly telephone call. Interventions including nutrition, physical activity and psychological well-being are stratified according to a patient’s priorities, level of readiness and expressed needs. The primary outcome will be feasibility of the personalised prehabilitation programme in clinical practice by investigating areas of uncertainty regarding patient recruitment, attrition, treatment fidelity, intervention adherence and acceptability of study outcome measures. Secondary outcomes will include quality of life, functional capacity and grip strength. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Health Research Authority (reference number 22/PR/0390). Results of this study will be disseminated through publication in peer-reviewed articles, presentations at scientific conferences and in collaboration with patient and public involvement representatives. TRIAL REGISTRATION NUMBER: NCT05318807. BMJ Publishing Group 2023-07-17 /pmc/articles/PMC10357652/ /pubmed/37460263 http://dx.doi.org/10.1136/bmjopen-2023-072367 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Oncology Wade-Mcbane, Kelly King, Alex Urch, Catherine Johansson, Lina Wells, Mary Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial |
title | Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial |
title_full | Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial |
title_fullStr | Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial |
title_full_unstemmed | Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial |
title_short | Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial |
title_sort | is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a london teaching hospital? protocol of a feasibility trial |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357652/ https://www.ncbi.nlm.nih.gov/pubmed/37460263 http://dx.doi.org/10.1136/bmjopen-2023-072367 |
work_keys_str_mv | AT wademcbanekelly ispersonalisedprehabilitationfeasibletoimplementforpatientsundergoingoncologicaltreatmentforlungcanceratalondonteachinghospitalprotocolofafeasibilitytrial AT kingalex ispersonalisedprehabilitationfeasibletoimplementforpatientsundergoingoncologicaltreatmentforlungcanceratalondonteachinghospitalprotocolofafeasibilitytrial AT urchcatherine ispersonalisedprehabilitationfeasibletoimplementforpatientsundergoingoncologicaltreatmentforlungcanceratalondonteachinghospitalprotocolofafeasibilitytrial AT johanssonlina ispersonalisedprehabilitationfeasibletoimplementforpatientsundergoingoncologicaltreatmentforlungcanceratalondonteachinghospitalprotocolofafeasibilitytrial AT wellsmary ispersonalisedprehabilitationfeasibletoimplementforpatientsundergoingoncologicaltreatmentforlungcanceratalondonteachinghospitalprotocolofafeasibilitytrial |